These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35067067)

  • 1. A Procedure for Eliciting Women's Preferences for Breast Cancer Screening Frequency.
    Grayek E; Yang Y; Fischhoff B; Schifferdecker KE; Woloshin S; Kerlikowske K; Miglioretti DL; Tosteson ANA
    Med Decis Making; 2022 Aug; 42(6):783-794. PubMed ID: 35067067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Eliciting women’s preferences for breast cancer screening].
    Sicsic J; Pelletier-Fleury N; Carretier J; Moumjid N
    Sante Publique; 2019; S2(HS2):7-17. PubMed ID: 32372583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk-Adapted Breast Screening for Women at Low Predicted Risk of Breast Cancer: An Online Discrete Choice Experiment.
    Kelley Jones C; Scott S; Pashayan N; Morris S; Okan Y; Waller J
    Med Decis Making; 2024 Jul; 44(5):586-600. PubMed ID: 38828503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eliciting women's cervical screening preferences: a mixed methods systematic review protocol.
    Wood B; Van Katwyk SR; El-Khatib Z; McFaul S; Taljaard M; Wright E; Graham ID; Little J
    Syst Rev; 2016 Aug; 5(1):136. PubMed ID: 27516072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of information about the benefits and harms of mammography on women's decision-making: study protocol for a randomized controlled trial.
    Carles M; Martínez-Alonso M; Pons A; Pérez-Lacasta MJ; Perestelo-Pérez L; Sala M; Vidal C; Garcia M; Toledo-Chávarri A; Codern N; Feijoo-Cid M; Romero A; Pla R; Soler-González J; Castells X; Rué M;
    Trials; 2017 Sep; 18(1):426. PubMed ID: 28899412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic review on women's values and preferences concerning breast cancer screening and diagnostic services.
    Mathioudakis AG; Salakari M; Pylkkanen L; Saz-Parkinson Z; Bramesfeld A; Deandrea S; Lerda D; Neamtiu L; Pardo-Hernandez H; Solà I; Alonso-Coello P
    Psychooncology; 2019 May; 28(5):939-947. PubMed ID: 30812068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Testing Theory-Based Messages to Encourage Women at Average Risk for Breast Cancer to Consider Biennial Mammography Screening.
    Guan Y; Haardörfer R; McBride CM; Escoffery C; Lipscomb J
    Ann Behav Med; 2023 Aug; 57(9):696-707. PubMed ID: 37155576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer screening in an era of personalized regimens: a conceptual model and National Cancer Institute initiative for risk-based and preference-based approaches at a population level.
    Onega T; Beaber EF; Sprague BL; Barlow WE; Haas JS; Tosteson AN; D Schnall M; Armstrong K; Schapira MM; Geller B; Weaver DL; Conant EF
    Cancer; 2014 Oct; 120(19):2955-64. PubMed ID: 24830599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Women's Benefits and Harms Trade-Offs in Breast Cancer Screening: Results from a Discrete-Choice Experiment.
    Sicsic J; Pelletier-Fleury N; Moumjid N
    Value Health; 2018 Jan; 21(1):78-88. PubMed ID: 29304944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for breast cancer: an update for the U.S. Preventive Services Task Force.
    Nelson HD; Tyne K; Naik A; Bougatsos C; Chan BK; Humphrey L;
    Ann Intern Med; 2009 Nov; 151(10):727-37, W237-42. PubMed ID: 19920273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
    Kerlikowske K; Zhu W; Hubbard RA; Geller B; Dittus K; Braithwaite D; Wernli KJ; Miglioretti DL; O'Meara ES;
    JAMA Intern Med; 2013 May; 173(9):807-16. PubMed ID: 23552817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating the Heterogeneity in Women's Preferences for Breast Screening: Does the Communication of Risk Matter?
    Vass CM; Rigby D; Payne K
    Value Health; 2018 Feb; 21(2):219-228. PubMed ID: 29477404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the Effects of Participant Preference and Demographics in the Usage of Web-based Survey Questionnaires by Women Attending Screening Mammography in British Columbia.
    Mlikotic R; Parker B; Rajapakshe R
    J Med Internet Res; 2016 Mar; 18(3):e70. PubMed ID: 27005707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantifying performance thresholds for recommending screening mammography: a revealed preference analysis of USPSTF guidelines.
    Narayan AK; Elkin EB; Lehman CD; Morris EA
    Breast Cancer Res Treat; 2018 Nov; 172(2):463-468. PubMed ID: 30128821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast Cancer Screening: Women's Attitudes and Beliefs in Light of Updated United States Preventive Services Task Force and American Cancer Society Guidelines.
    Mehta JM; MacLaughlin KL; Millstine DM; Faubion SS; Wallace MR; Shah AA; Fields HE; Ruddy BE; Bryan MJ; Patel B; Temkit MH; Buras MR; Golafshar MA; Kling JM
    J Womens Health (Larchmt); 2019 Mar; 28(3):302-313. PubMed ID: 30204537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Age, Race, and Socioeconomic Status on Women's Perceptions and Preferences Regarding Communication of Estimated Breast Cancer Risk.
    Amornsiripanitch N; Ameri SM; Goldberg RJ
    Acad Radiol; 2021 May; 28(5):655-663. PubMed ID: 32376184
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.